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Human rhinoviruses, the major cause of mild recurrent infections of
the upper respiratory tract, are small icosahedral particles. Over 100
different serotypes have been identi®ed. The majority (91 serotypes)
use intercellular adhesion molecule 1 as the cell-attachment site; ten
serotypes (the minor group) bind to members of the low-density
lipoprotein receptor. Three different crystal forms of the minor-group
human rhinovirus serotype 2 (HRV2) were obtained by the hanging-
drop vapour-diffusion technique using ammonium sulfate and
sodium/potassium phosphate as precipitants. Monoclinic crystals,
space group P21, diffracted at least to 2.8 AÊ resolution, and two
complete virus particles were located in the crystal asymmetric unit.
A second type of crystals had a compact cubic like morphology and
diffracted beyond 2.5 AÊ resolution. These crystals belong to a
primitive orthorhombic space group, with unit-cell parameters
a = 309.3, b = 353.5, c = 759.6 AÊ , and contain one virus particle in
the asymmetric unit. A third type of crystals, with a prismatic shape
and belonging to space group I222, was also obtained under similar
crystallization conditions. These latter crystals, with unit-cell para-
meters a = 308.7, b = 352.2, c = 380.5 AÊ , diffracted to high resolution
(beyond 1.8 AÊ ) and contained 15 protomers per asymmetric unit; this
requires that three perpendicular crystal twofold axes coincide with
three of the viral particle's dyad axes.
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1. Introduction
About 50% of all common cold infections are
caused by human rhinoviruses (HRVs). 102
different serotypes have been identi®ed to
date; this large number allows frequent re-
infections of the same individual by different
serotypes during the life span. HRVs are small
(35 nm in diameter) icosahedral particles
which are composed of 60 copies of the four
viral proteins VP1, VP2, VP3 and VP4. The
capsid encloses the genomic positive
(messenger) sense RNA (for a review, see
Rueckert, 1996). The majority of the HRV
serotypes (91) use intercellular adhesion
molecule 1 (ICAM-1) as the cell-attachment
site; the minor group (ten serotypes) bind to
members of the low-density lipoprotein (LDL)
receptor (Hofer et al., 1994). Only HRV87
appears to gain access to the host cell via an
uncharacterized glycoprotein (Uncapher et al.,
1991). Determination of the three-dimensional
structures of three major-group viruses
(HRV3, Zhao et al., 1996; HRV14, Rossmann et
al., 1985; HRV16, Oliveira et al., 1993) and one
minor-group virus (HRV1A, Kim et al., 1989)
by X-ray crystallography revealed a high
degree of similarity between the various sero-
types, regardless of their belonging to the
major or to the minor receptor group; only the
antigenic epitopes differ substantially.
Recently, the structure of the two N-term-
inal domains of human ICAM-1 was solved
(Bella et al., 1998; Casasnovas et al., 1998). In
combination with the low-resolution structure
of a complex between HRV16 and soluble
recombinant ICAM-1 (Olson et al., 1993), a
model was constructed which allowed a tenta-
tive identi®cation of amino-acid residues on
the viral surface involved in contacts with
ICAM-1. These amino acids turned out to be
highly conserved within HRVs, even including
the minor receptor group virus HRV1A (Bella
et al., 1998). Clues as to why minor-group
viruses do not use ICAM-1 as the viral
receptor might be obtained from comparison
of the structures available so far with that of
HRV2, another minor receptor group HRV.
Monoclonal antibodies neutralize HRVs by
viral aggregation, inhibition of cell attachment
or of release of the genomic RNA into the
cytosol, or by combinations of these.
Complexes between HRV14 (Smith et al., 1995;
Smith, Olson, Cheng, Chase et al., 1993; Smith,
Olson, Cheng, Liu et al., 1993) or HRV2
(Hewat & Blaas, 1996; Hewat et al., 1998) with
monoclonal antibodies neutralizing the
respective serotypes have been solved to low
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resolution by electron cryo-microscopy.
However, important structural details
required for ef®cient neutralization can only
be seen at high resolution. This either
requires crystallization of the complex
(Smith et al., 1996) or extension of the
resolution by combining electron micro-
scopy data with X-ray data of the compo-
nents (i.e. from virus and from antibody or
receptor; Bella et al., 1998). The structure of
at least one of the HRV2-neutralizing anti-
bodies is available at atomic resolution
(Tormo et al., 1992, 1994) and a model of the
viral complex was built using the data of
HRV1A. However, although closely related
to HRV2, this serotype has substantially
different neutralizing immunogens (Tormo
et al., 1995), which prevents reliable predic-
tions of the antibody±virus interface.
For the reasons given above, we felt it
highly desirable to solve the structure of
HRV2, an extensively characterized minor-
group rhinovirus. In the current paper, we
report the crystallization of HRV2 and the
arrangement of the viral particles within the
unit cell.
2. Experimental
HRV2, originally obtained from Dr D.
Tyrrell, Common Cold Centre, Salisbury,
England, was routinely grown in Rhino
HeLa cells (Flow Laboratories) maintained
in 1 l suspension cultures at 307 K (Skern et
al., 1984). About 40 h post-infection, at a
multiplicity of infection of 1, cells and cell
debris were collected by low-speed centri-
fugation, cells were broken with a Dounce
homogenizer and the virus was collected by
differential centrifugation. Virus pellets
from a 4 l tissue culture were suspended in
1 ml 20 mM Tris±HCl (pH 7.5), 2 mM MgCl2
(virus buffer) and digested with RNAase I
and DNAase (Boehringer Mannheim) at a
®nal concentration of 0.25 mg mlÿ1 for
10 min at room temperature. Trypsin
(GIBCO) was then added to 0.3 mg mlÿ1
and incubation was continued for 5 min at
310 K. The solution was adjusted to 1%
N-laurylsarcosine and left overnight at
277 K. Insoluble material was removed at
14000 rev minÿ1 for 15 min in an Eppendorf
centrifuge. The virus in the supernatant was
laid on top of a 7±45% sucrose density
gradient prepared in virus buffer and
centrifuged in a SW28 Beckman rotor at
25000 rev minÿ1 for 3.5 h. The virus was
detected as an opalescent band in the middle
of the gradient and was collected by punc-
turing the tube with a needle. After dilution
with buffer, HRV2 was pelleted by high-
speed centrifugation and resuspended in
300 ml 50 mM Tris±HCl (pH 7.4). The quality
of different viral preparations was judged by
denaturing polyacrylamide gel electrophor-
esis and conventional negative-staining
transmission electron microscopy. For crys-
tallization, only preparations containing
more than 95% native virions, as seen from
the absence of stain inside the particles, were
used.
HRV2 crystallized in three different
crystal morphologies (Fig. 1) using the
hanging-drop vapour-diffusion method.
Typically, 2±5 ml of virus solution
(5 mg mlÿ1) in 50 mM Tris±HCl (pH 7.4)
was mixed with an equal or smaller volume
of reservoir solution. Parallelepiped-shaped
crystals (Fig. 1a), growing to approximately
0.6 0.2 0.15 mm in size, were obtained at
0.9±1.0 M ammonium sulfate and 0.1 M
sodium/potassium phosphate at pH 7.0.
These crystals appeared within 3±5 d at
room temperature and diffracted at least to
2.8 AÊ resolution using synchrotron radia-
tion. Partial data sets were collected at the
Science and Engineering Research Council's
Synchrotron Radiation Source (SRS) facility
at Daresbury, Cheshire, England. Data
collection was performed at beamline
station 9.6 at a wavelength of 0.88 AÊ using
ADSC Quantum 4 CCD and MAR 345
detectors. Crystals belong to the monoclinic
space group P21, and packing considerations
indicated that they could contain two virions
in the asymmetric unit yielding 120-fold non-
crystallographic symmetry (Table 1). A
second crystal form with a cubic like
morphology (Fig. 1b) was obtained at room
temperature at pH 7.5 using 0.2 M ammo-
nium sulfate and 0.1 M sodium/potassium
phosphate as precipitants. Crystals appeared
within a month, reaching sizes of 0.3 0.3
0.15 mm. A similar crystal morphology also
grew at 277 K in 2±3% PEG 8000 and 0.1 M
sodium/potassium phosphate at pH 7.5.
These crystals diffracted at least to 2.5 AÊ
resolution using synchrotron radiation
(beamline X11 at DESY, Hamburg), but
were stable in the X-ray beam for only 1±2
exposures. The unit cell, characterized using
0.3 rotation diffraction images analyzed
with the MOSFLM package (Leslie, 1992),
was consistent with a primitive ortho-
rhombic space group (Table 1). From the
unit-cell dimensions, one virus particle is
expected to be found per asymmetric unit
(60-fold non-crystallographic symmetry). A
third type of crystals with prismatic
morphology and dimensions up to 0.3  0.2
 0.15 mm was also obtained at room
temperature and pH 7.5 using 0.4 M
ammonium sulfate and 0.1 M sodium/
potassium phosphate (Fig. 1c). These crys-
tals, with unit-cell parameters a = 308.7,
b = 352.2, c = 380.5 AÊ , diffracted to high
resolution (beyond 1.8 AÊ ); however, they
were extremely sensitive to X-ray radiation.
A data set at 2.5 AÊ resolution was collected
from 65 crystals mounted in sealed capillary
tubes using synchrotron radiation (= 0.96 AÊ
at beamline X11 at DESY, Hamburg). Data
was evaluated using the MOSFLM (Leslie,
Figure 1
Photomicrographs of the HRV2 crystals: (a) monoclinic P21, (b) primitive orthorhombic and (c) body-centred
orthorhombic I222.
Table 1
HRV2 crystal parameters.
Space group
Resolution
(AÊ )
Unit-cell parameters
(AÊ , )
Virions
per cell
Packing density²
(AÊ 3 Daÿ1)
P21 2.8 a = 469.3, b = 381.8,
c = 472.4;  = 98.6
4 2.8
Primitive
orthorhombic
2.5 a = 309.3, b = 353.3,
c = 759.6
4 2.8
I222 1.8 a = 308.7, b = 352.2,
c = 380.5
2 2.8
² Calculated assuming a relative mass per virion of 7.5  106 Da.
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1992) and DENZO (Otwinowski & Minor,
1996) packages (Table 2). The crystals
belong to the orthorhombic space group
I222 (Table 1) and contain two virions per
unit cell (15 protomers per asymmetric unit),
which requires that three perpendicular
crystal twofold axes coincide with three of
the viral particle's dyad axes. Therefore, the
centres of the two virion particles in the unit
cell had to be located at (0, 0, 0) and (12,
1
2,
1
2),
with the particles oriented in one of only two
possible orientations. These two alternative
orientations are related by a 90 rotation
around any of the three coincident twofold
axes. Structure determination was per-
formed using molecular replacement with
the X-PLOR (BruÈ nger, 1992) and DM
(Cowtan, 1994) programs, using as starting
models the coordinates of the minor-group
rhinovirus HRV1A in the two possible
orientations. The initial R factors calculated
for the two search models were 50.0 and
36.0%, respectively, for data to 3.5 AÊ reso-
lution, thus providing an unambiguous
discrimination, clearer than the self-rotation
function, between the two alternative
orientations. Structure re®nement on this
I222 crystal form is now in progress.
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